CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $30,622,000 | +22.0% | 200,000 | -33.3% | 0.73% | -24.5% |
Q3 2020 | $25,092,000 | -14.6% | 300,000 | -25.0% | 0.96% | -14.0% |
Q2 2020 | $29,396,000 | +10.0% | 400,000 | -36.5% | 1.12% | -9.7% |
Q1 2020 | $26,735,000 | -56.1% | 630,400 | -37.0% | 1.24% | -48.9% |
Q4 2019 | $60,905,000 | +37.0% | 1,000,000 | -7.8% | 2.43% | -10.2% |
Q3 2019 | $44,445,000 | +34.8% | 1,084,300 | +54.9% | 2.70% | +42.8% |
Q2 2019 | $32,970,000 | +2.6% | 700,000 | -22.2% | 1.89% | -12.8% |
Q1 2019 | $32,148,000 | +1025.2% | 900,000 | +800.0% | 2.17% | +836.6% |
Q4 2018 | $2,857,000 | – | 100,000 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |